Total Payments
$6,593
2024 Payments
$0
Companies
34
Transactions
207
Medicare Patients
3,935
Medicare Billing
$335,132
Payment Breakdown by Category
Food & Beverage$3,278 (49.7%)
Consulting$2,375 (36.0%)
Travel$724.83 (11.0%)
Gifts$191.37 (2.9%)
Education$24.02 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,278 | 172 | 49.7% |
| Consulting Fee | $2,375 | 1 | 36.0% |
| Travel and Lodging | $724.83 | 3 | 11.0% |
| Gift | $191.37 | 13 | 2.9% |
| Education | $24.02 | 14 | 0.4% |
| Unspecified | $0 | 4 | 0.0% |
Payments by Type
General
$6,593
203 transactions
Ownership
$0
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $3,273 | 9 | $0 (2018) |
| AbbVie Inc. | $643.85 | 35 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $328.50 | 19 | $0 (2023) |
| Aries Pharmaceuticals, Inc. | $322.70 | 4 | $0 (2018) |
| Janssen Biotech, Inc. | $299.39 | 17 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $262.71 | 16 | $0 (2023) |
| PFIZER INC. | $248.60 | 17 | $0 (2023) |
| Braintree Laboratories, Inc. | $243.94 | 27 | $0 (2022) |
| Organon LLC | $139.94 | 5 | $0 (2023) |
| Gilead Sciences, Inc. | $80.18 | 5 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $0 | 1 | GastroGPO, LLC |
| 2023 | $934.36 | 50 | AbbVie Inc. ($264.12) |
| 2022 | $914.49 | 54 | ABBVIE INC. ($263.09) |
| 2021 | $437.80 | 42 | Braintree Laboratories, Inc. ($110.69) |
| 2020 | $186.74 | 8 | Braintree Laboratories, Inc. ($65.35) |
| 2019 | $198.31 | 14 | PFIZER INC. ($55.80) |
| 2018 | $543.75 | 15 | Aries Pharmaceuticals, Inc. ($322.70) |
| 2017 | $3,378 | 23 | E.R. Squibb & Sons, L.L.C. ($3,182) |
All Payment Transactions
207 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 2024 | GastroGPO, LLC | — | — | — | $0.00 | Ownership |
| 12/12/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Immunology | ||||||
| 12/11/2023 | Organon LLC | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $34.30 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 12/04/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $8.36 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Gastroenterology | ||||||
| 11/14/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/09/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Gastroenterology | ||||||
| 10/25/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Gastroenterology | ||||||
| 10/21/2023 | AbbVie Inc. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: IMMUNOLOGY | ||||||
| 10/18/2023 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $22.91 | General |
| 09/27/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: Gastroenterology | ||||||
| 09/13/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: IMMUNOLOGY | ||||||
| 09/11/2023 | Organon LLC | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $26.90 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 09/05/2023 | Medtronic, Inc. | GI GENIUS (Device) | Food and Beverage | In-kind items and services | $20.99 | General |
| Category: Gastrointestinal AI | ||||||
| 08/22/2023 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/16/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Immunology | ||||||
| 08/14/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/12/2023 | AbbVie Inc. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: IMMUNOLOGY | ||||||
| 08/07/2023 | Organon LLC | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $33.63 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 07/26/2023 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 07/15/2023 | AbbVie Inc. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: IMMUNOLOGY | ||||||
| 07/12/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), PLENVU | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Gastroenterology | ||||||
| 06/28/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Immunology | ||||||
| 06/12/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: INFECTIOUS DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 533 | 1,182 | $395,986 | $78,254 |
| 2022 | 15 | 736 | 1,094 | $444,605 | $82,470 |
| 2021 | 23 | 1,261 | 1,480 | $495,010 | $86,471 |
| 2020 | 26 | 1,405 | 1,699 | $521,157 | $87,937 |
Total Patients
3,935
Total Services
5,455
Medicare Billing
$335,132
Procedure Codes
76
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 115 | 115 | $122,705 | $22,318 | 18.2% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 46 | 454 | $69,008 | $15,567 | 22.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 47 | 260 | $26,000 | $11,662 | 44.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 79 | 82 | $55,760 | $5,799 | 10.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 47 | 56 | $12,152 | $5,008 | 41.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 46 | 46 | $38,962 | $4,393 | 11.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 56 | 65 | $9,620 | $3,771 | 39.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 18 | 18 | $14,004 | $3,029 | 21.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 20 | 20 | $15,620 | $2,633 | 16.9% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 15 | 21 | $13,629 | $2,097 | 15.4% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 19 | 19 | $9,842 | $1,217 | 12.4% |
| 43450 | Dilation of esophagus | Facility | 2023 | 25 | 26 | $8,684 | $760.22 | 8.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 131 | 132 | $140,844 | $24,287 | 17.2% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 39 | 262 | $39,824 | $9,224 | 23.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 87 | 90 | $59,790 | $6,877 | 11.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 39 | 141 | $14,100 | $6,599 | 46.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 68 | 68 | $57,596 | $6,139 | 10.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 32 | 32 | $24,896 | $5,475 | 22.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 52 | 54 | $15,012 | $5,451 | 36.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 38 | 42 | $9,114 | $3,479 | 38.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 44 | 60 | $8,760 | $3,212 | 36.7% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 39 | 40 | $20,720 | $3,165 | 15.3% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 25 | 26 | $20,294 | $3,131 | 15.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 41 | 44 | $6,512 | $2,546 | 39.1% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 14 | 15 | $9,735 | $1,656 | 17.0% |
About Dr. Gary Thomas, MD
Dr. Gary Thomas, MD is a Gastroenterology healthcare provider based in Fayetteville, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831125731.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Thomas, MD has received a total of $6,593 in payments from pharmaceutical and medical device companies, with $0 received in 2024. These payments were reported across 207 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($3,278).
As a Medicare-enrolled provider, Thomas has provided services to 3,935 Medicare beneficiaries, totaling 5,455 services with total Medicare billing of $335,132. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Fayetteville, AR
- Active Since 06/23/2006
- Last Updated 11/02/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1831125731
Products in Payments
- OPDIVO (Biological) $3,273
- ELEVIEW (Device) $322.70
- XIFAXAN (Drug) $304.78
- ENTYVIO (Biological) $249.19
- XELJANZ (Drug) $238.07
- RINVOQ (Biological) $223.90
- STELARA (Biological) $183.27
- SKYRIZI (Biological) $181.65
- SUTAB (Drug) $163.81
- HUMIRA (Biological) $124.09
- DUPIXENT (Biological) $117.63
- REMICADE (Biological) $116.12
- HADLIMA (Drug) $94.83
- ZEPOSIA (Drug) $65.26
- SUPREP BOWEL PREP (Drug) $53.32
- RENFLEXIS (Drug) $45.11
- TRULANCE (Drug) $39.48
- AVSOLA (Biological) $38.91
- CREON (Drug) $38.58
- OCALIVA (Drug) $38.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Fayetteville
Dr. John Poulos, M.d, M.D
Gastroenterology — Payments: $510,536
Gastroenterology $510,536
Dr. Joseph Henderson, D.o, D.O
Gastroenterology — Payments: $29,308
Gastroenterology $29,308
Dr. Bryan Woods, M.d, M.D
Gastroenterology — Payments: $7,356
Gastroenterology $7,356
Dr. John Burney, M.d, M.D
Gastroenterology — Payments: $6,254
Gastroenterology $6,254
Dr. David Gryboski, M.d, M.D
Gastroenterology — Payments: $5,126
Gastroenterology $5,126
Dr. Kiran Kanji, M.d, M.D
Gastroenterology — Payments: $4,993
Gastroenterology $4,993